Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Cytisine for smoking cessation: a research agenda.

Etter JF, Lukas RJ, Benowitz NL, West R, Dresler CM.

Drug Alcohol Depend. 2008 Jan 1;92(1-3):3-8. Epub 2007 Sep 6. Review.

PMID:
17825502
2.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T.

Cochrane Database Syst Rev. 2016 May 9;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. Review.

PMID:
27158893
3.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006103. Review. Update in: Cochrane Database Syst Rev. 2008;(3):CD006103.

PMID:
17253581
4.

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.

Tutka P.

Expert Opin Investig Drugs. 2008 Oct;17(10):1473-85. doi: 10.1517/13543784.17.10.1473 . Review.

PMID:
18808308
5.

Cytisine for smoking cessation: a literature review and a meta-analysis.

Etter JF.

Arch Intern Med. 2006 Aug 14-28;166(15):1553-9. Review.

PMID:
16908787
6.

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.

Walker N, Howe C, Bullen C, McRobbie H, Glover M, Parag V, Williman J, Veale R, Nosa V, Barnes J.

BMC Public Health. 2011 Nov 21;11:880. doi: 10.1186/1471-2458-11-880.

7.

An uncontrolled trial of cytisine (Tabex) for smoking cessation.

Zatonski W, Cedzynska M, Tutka P, West R.

Tob Control. 2006 Dec;15(6):481-4.

8.

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.

Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A.

Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330. Review.

9.

Cytisine versus nicotine for smoking cessation.

Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C.

N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.

10.

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.

Tutka P, Zatoński W.

Pharmacol Rep. 2006 Nov-Dec;58(6):777-98. Review.

11.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
12.

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE.

Neuropharmacology. 2007 Mar;52(3):985-94. Epub 2006 Dec 8.

PMID:
17157884
13.
14.

Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.

Rollema H, Shrikhande A, Ward KM, Tingley FD 3rd, Coe JW, O'Neill BT, Tseng E, Wang EQ, Mather RJ, Hurst RS, Williams KE, de Vries M, Cremers T, Bertrand S, Bertrand D.

Br J Pharmacol. 2010 May;160(2):334-45. doi: 10.1111/j.1476-5381.2010.00682.x. Epub 2010 Mar 22.

15.

An update on therapeutics for tobacco dependence.

Lancaster T, Stead L, Cahill K.

Expert Opin Pharmacother. 2008 Jan;9(1):15-22. Review.

PMID:
18076335
16.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
17.

[Safety of nicotine addiction treatment].

Korzeniowska K, Cieślewicz A, Jabłecka A.

Przegl Lek. 2013;70(10):839-41. Polish.

PMID:
24501808
18.

Varenicline: progress in smoking cessation treatment.

Glover ED, Rath JM.

Expert Opin Pharmacother. 2007 Aug;8(11):1757-67. Review.

PMID:
17685891
19.

Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews.

Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T.

Addiction. 2013 Oct;108(10):1711-21. doi: 10.1111/add.12291. Epub 2013 Aug 14.

PMID:
23834141
20.

Cytisine's potential to be used as a traditional healing method to help indigenous people stop smoking: a qualitative study with Māori.

Thompson-Evans TP, Glover MP, Walker N.

Nicotine Tob Res. 2011 May;13(5):353-60. doi: 10.1093/ntr/ntr002. Epub 2011 Mar 8.

PMID:
21385905

Supplemental Content

Support Center